Ryan F. Robinson is CFO of Talaris Therapeutics, Inc.. Currently has a direct ownership of 14,366 shares of TALS, which is worth approximately $39,075. The most recent transaction as insider was on Oct 22, 2025, when has been sold 14,366 shares (Common Stock) at a price of $13.92 per share, resulting in proceeds of $199,974. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.4K
n/a 3M change
n/a 12M change
Total Value Held $39,075

Ryan F. Robinson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2025
BUY
Exercise of conversion of derivative security
$199,974 $13.92 p/Share
14,366 Added 50.0%
14,366 Common Stock
RFR

Ryan F. Robinson

CFO
New York, NY

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Track Activities on TALS